This finding highlights a previously underexplored compensatory mechanism that may help melanomas to sustain their growth and progression through alternative lipid metabolic pathways characterized by high SAG, 2-AG, and ARA levels and CES1/Ces1 overexpression in a subtype of BRAFV600E-driven malignant melanoma. The gene discussed is CES1; the disease is melanoma.